These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11302924)

  • 1. Atypical antipsychotics in the treatment of schizophrenia. Users' experiences of treatments must be considered.
    Prior C; Clements J; Rowett M
    BMJ; 2001 Apr; 322(7291):924-5; author reply 927-8. PubMed ID: 11302924
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical antipsychotics in the treatment of schizophrenia. Users' views are important.
    Anderson I
    BMJ; 2001 Apr; 322(7291):926; author reply 927-8. PubMed ID: 11302919
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring for metabolic complications associated with atypical antipsychotics.
    Farver D
    S D J Med; 2005 Feb; 58(2):53-4. PubMed ID: 15756776
    [No Abstract]   [Full Text] [Related]  

  • 4. Antipsychotic safety and efficacy concerns.
    Meyer JM
    J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
    Vohora D
    Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic treatment of adolescent and child schizophrenia.
    Young CM; Findling RL
    Expert Rev Neurother; 2004 Jan; 4(1):53-60. PubMed ID: 15853615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing tolerability profiles among atypical antipsychotics.
    Hellewell JS; Haddad PM
    Am J Psychiatry; 2001 Mar; 158(3):501-2. PubMed ID: 11230007
    [No Abstract]   [Full Text] [Related]  

  • 9. [From neuroleptics toward antipsychotics: quality of life and schizophrenia].
    Lançon C
    Encephale; 2003 Sep; 29(Pt 2):S43-6. PubMed ID: 14710537
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fourth conference. Why atypical antipsychotics are really atypical?].
    Weinberger DR
    Vertex; 2002; 13 Suppl():37-47. PubMed ID: 12478308
    [No Abstract]   [Full Text] [Related]  

  • 12. Varying and "atypical" indications for atypical antipsychotics.
    Barbui C; Tansella M; Garattini S
    Psychopharmacology (Berl); 2003 Sep; 169(2):205-6. PubMed ID: 12761607
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular risks of atypical antipsychotic drug treatment.
    Drici MD; Priori S
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):882-90. PubMed ID: 17563919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.
    Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ;
    Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
    Ollendorf DA; Joyce AT; Rucker M
    MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials.
    Stahl SM
    J Clin Psychiatry; 1999; 60 Suppl 10():31-41. PubMed ID: 10340685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of bipolar disorder with antipsychotic medication: issues shared with schizophrenia.
    Young AH
    J Clin Psychiatry; 2007; 68 Suppl 6():24-5. PubMed ID: 17650056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation antipsychotics: looking beyond efficacy.
    Awad AG
    Can J Psychiatry; 2004 May; 49(5):283-4. PubMed ID: 15198462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.